An Observational Study to Evaluate the Effects of Long-term Use of Psychotropic Medications on Eye Movement Patterns With the Gaize Device (Rx Meds Gaize)

NCT07389473 RECRUITING

The study aims to verify if the Gaize ocular device can effectively identify eye movements indicative of prescribed psychotropic medication usage by employing Drug Recognition Expert (DRE) testing protocols within a controlled virtual environment.

Details

Lead sponsor	Gaize
Status	RECRUITING
Enrolment	50
Start date	2024-04-17
Completion	2028-08

Conditions

• ADHD
• Depression Disorders
• Mood Disorders
• Anxiety Disorder Generalized
• Bipolar Disorder (BPD)

Interventions

• Prescription Psychotropic Medications

Primary outcomes

• Collection of Ophthalmic Data — 1 Day
  Accuracy of the Gaize device in detecting eye-movement metrics consistent with prescribed psychotropic medication use, as determined by Drug Recognition Expert (DRE) testing protocols in a controlled virtual environment.

Countries

United States